Sunshine Biopharma, Inc., a company operating within the health care sector, specifically in the biotechnology industry, has been making strides in the pharmaceutical landscape. As a publicly traded entity on the Nasdaq stock exchange, Sunshine Biopharma focuses on the research, development, and commercialization of oncology and antiviral drugs, alongside science-based nutritional supplements. The company’s global operations enable it to serve a diverse customer base worldwide.

As of September 14, 2026, the close price of Sunshine Biopharma’s stock was recorded at $1.03. This figure is notably close to the 52-week low of $1.01, observed on August 25, 2026. In contrast, the company’s 52-week high was $24.3, achieved on October 15, 2025. These fluctuations in stock price reflect the dynamic nature of the biotechnology sector and the challenges faced by companies within this industry.

The market capitalization of Sunshine Biopharma stands at $4,110,000 USD, indicating the total market value of its outstanding shares. This valuation is a critical metric for investors assessing the company’s size and financial health. Additionally, the price-to-earnings (P/E) ratio of -0.102 suggests that the company is currently not generating positive earnings, which is not uncommon for companies heavily invested in research and development.

Sunshine Biopharma’s commitment to advancing medical science is evident in its focus on oncology and antiviral drugs. These areas are of significant importance due to the ongoing global health challenges posed by cancer and viral infections. The company’s efforts in developing innovative treatments and supplements are aimed at improving patient outcomes and enhancing quality of life.

For those interested in learning more about Sunshine Biopharma’s activities, offerings, and strategic direction, further information is available on their official website at www.sunshinebiopharma.com . This platform provides insights into the company’s mission, research initiatives, and future prospects in the biotechnology field.